Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2002-11-13
2008-05-13
Richter, Johann (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252130, C514S277000, C514S449000, C514S520000, C544S158000, C544S159000, C544S383000, C544S392000, C544S393000, C546S262000, C546S265000, C549S491000, C558S190000, C558S391000, C558S392000, C558S436000, C558S445000
Reexamination Certificate
active
07371747
ABSTRACT:
The present invention is directed to novel cyanoalkylamino derivatives that are inhibitors of cysteine protease such as cathepsins K, S, B and L, in particular cathepsin K Pharmaceutical composition comprising these compounds, method of treating diseases mediated by unregulated cysteine protease activity, in particular cathepsin K utilizing these compounds and methods of preparing these compounds are also disclosed.
REFERENCES:
patent: WO 00/55125 (2000-09-01), None
Black Cameron
Crane Sheldon N.
Davis Dana
Setti Eduardo L.
Beeler Nicole A.
Merck Frosst Canada & Co.
Muthard David A.
Richter Johann
Sackey Ebenezer
LandOfFree
Cyanoalkylamino derivatives as protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyanoalkylamino derivatives as protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyanoalkylamino derivatives as protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3983280